251 related articles for article (PubMed ID: 27376874)
1. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.
Sahini N; Borlak J
Transl Res; 2016 Nov; 177():41-69. PubMed ID: 27376874
[TBL] [Abstract][Full Text] [Related]
2. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
4. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades.
Liu Z; Wang Y; Borlak J; Tong W
Sci Rep; 2016 Apr; 6():23709. PubMed ID: 27045805
[TBL] [Abstract][Full Text] [Related]
5. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity.
Ferri F; Carotti S; Carpino G; Mischitelli M; Cantafora A; Molinaro A; Argenziano ME; Parisse S; Corsi A; Riminucci M; Lai Q; Mennini G; Spadetta G; Pugliese F; Rossi M; Morini S; Gaudio E; Ginanni Corradini S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198853
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
Jin Y; Tan Y; Chen L; Liu Y; Ren Z
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
[TBL] [Abstract][Full Text] [Related]
8. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
[TBL] [Abstract][Full Text] [Related]
9. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.
Zhang X; Wang Y; Liu P
Protein Cell; 2017 Jan; 8(1):4-13. PubMed ID: 27757845
[TBL] [Abstract][Full Text] [Related]
10. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha.
Graffmann N; Ring S; Kawala MA; Wruck W; Ncube A; Trompeter HI; Adjaye J
Stem Cells Dev; 2016 Aug; 25(15):1119-33. PubMed ID: 27308945
[TBL] [Abstract][Full Text] [Related]
11. Perilipin discerns chronic from acute hepatocellular steatosis.
Pawella LM; Hashani M; Eiteneuer E; Renner M; Bartenschlager R; Schirmacher P; Straub BK
J Hepatol; 2014 Mar; 60(3):633-42. PubMed ID: 24269473
[TBL] [Abstract][Full Text] [Related]
12. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
[TBL] [Abstract][Full Text] [Related]
13. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M
FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription.
Huang F; Liu H; Lei Z; Li Z; Zhang T; Yang M; Zhou K; Sun C
J Cell Physiol; 2020 Dec; 235(12):9819-9833. PubMed ID: 32413192
[TBL] [Abstract][Full Text] [Related]
18. Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes.
Xu W; Wu L; Yu M; Chen FJ; Arshad M; Xia X; Ren H; Yu J; Xu L; Xu D; Li JZ; Li P; Zhou L
J Biol Chem; 2016 Feb; 291(9):4282-93. PubMed ID: 26733203
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of lipid droplet proteins in liver diseases.
Carr RM; Ahima RS
Exp Cell Res; 2016 Jan; 340(2):187-92. PubMed ID: 26515554
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease.
Wang R; Wang X; Zhuang L
Ann Hepatol; 2016; 15(2):190-9. PubMed ID: 26845596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
